The MVIS® US Listed Semiconductor 25 Index (MVSMH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the semiconductor industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from semiconductors or semiconductor equipment.
Full MCap of at least 150 mln USD. Three month average-daily-trading volume of at least 1 mln USD at a review and also at the previous two reviews. At least 250,000 shares traded per month over the last six months at a review and also at the previous two reviews.
Pure-Play
Companies have to generate at least 50% revenues from semiconductors.
Diversification
Company weightings are capped at 20%.
Review
Semi-annually in March and September with quarterly rebalances.
A license agreement is required to use MarketVector indexes, index data or trademarks for various commercial purpose. These include research and analysis, as well as the creation, introduction, promotion, or marketing of financial products such as exchange-traded products, mutual funds, certificates, derivatives, swaps, bonds, or OTC products connected to or derived from MarketVectorTM Indexes.
We can help you learn more about acquiring a suitable license for your needs.
MVIS® US Listed Semiconductor 10% Capped ESG Index
The MVIS® US Listed Semiconductor 10% Capped ESG Index (MVSMC) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the semiconductor industry, employing a 10% capping scheme. MVSMC only includes companies that generate at least 50% of their revenue from semiconductors or semiconductor equipment.
The MVIS® US Business Development Companies Index (MVBDC) tracks the performance of the largest and most liquid Business Development Companies that are listed and incorporated in the United States. This is a modified market cap-weighted index, and only includes companies that qualify as a Business Development Company, which means it must be organized under the laws of, and have its principal place of business in the U.S., be registered with the Securities Exchange Commision, and have elected to be regulated as a BDC under the Investment Company Act of 1940.
The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.